<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04943172</url>
  </required_header>
  <id_info>
    <org_study_id>P061</org_study_id>
    <nct_id>NCT04943172</nct_id>
  </id_info>
  <brief_title>The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study</brief_title>
  <official_title>The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis (SAVVE) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hancock Jaffe Laboratiores, Inc</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AXIOM Real Time Metrics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Syntactx</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hancock Jaffe Laboratiores, Inc</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, non blinded, single arm, multicenter study designed to assess the safety and&#xD;
      effectiveness of the bioprosthetic, VenoValve, which is surgically implanted into the deep&#xD;
      venous system for treatment of patients with deep venous valvular insufficiency ( C4b-C6&#xD;
      patients).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the VenoValve System (Hancock Jaffe Laboratories) in&#xD;
      human patients. The VenoValve System is designed for treatment of chronic deep venous&#xD;
      insufficiency. The VenoValve System enables improvement in chronic lower extremity venous&#xD;
      reflux through an open surgical technique. The objective of this study is to assess the&#xD;
      safety and effectiveness of the VenoValve System for the treatment of patients with deep&#xD;
      venous valvular insufficiency and the associated complications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 27, 2021</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Open Label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The primary safety endpoint is the composite of the following Major Adverse Events:</measure>
    <time_frame>30 days</time_frame>
    <description>Death, Major Bleeding, Deep Wound Infection, Ipsilateral deep vein thrombosis, Pulmonary embolism in 75 patients. Rate of &gt;9% is expected</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Event rates</measure>
    <time_frame>3, 6, 12 months and annually thereafter through 5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Deep Venous Insufficiency (Diagnosis)</condition>
  <arm_group>
    <arm_group_label>VenoValve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects who receive VenoValve implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hancock-Jaffe bioprosthetic venous valve (VenoValve®)</intervention_name>
    <description>Surgical implantation of the VenoValve device</description>
    <arm_group_label>VenoValve</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Failure of at least 3 months of standard care including compression therapy, and in C6&#xD;
             patients, wound care,&#xD;
&#xD;
          2. Axial deep reflux &gt;1000 msec. at the level of the popliteal vein&#xD;
&#xD;
          3. Venous valvular incompetence from primary or secondary causes, e.g., post-thrombotic&#xD;
             syndrome (PTS),&#xD;
&#xD;
          4. CEAP score: C4b, C4c, C5, or C6,&#xD;
&#xD;
          5. Diameter of native target vein ≥8 mm,&#xD;
&#xD;
          6. Age ≥18 years,&#xD;
&#xD;
          7. Ability to tolerate duplex ultrasound,&#xD;
&#xD;
          8. Ability to ambulate without assistance,&#xD;
&#xD;
          9. Able to attend scheduled post-treatment follow-up visits,&#xD;
&#xD;
         10. BMI &lt;40,&#xD;
&#xD;
         11. Willing and able to comply with all compulsory study procedures and provide informed&#xD;
             consent prior to any study procedures being performed,&#xD;
&#xD;
         12. Negative COVID-19 test within 6 days of index procedure or record of full vaccination&#xD;
             for COVID-19,&#xD;
&#xD;
         13. Female patients of childbearing potential must:&#xD;
&#xD;
               -  have negative pregnancy test at the screening visit or within 7 days of the index&#xD;
                  procedure, whichever is later,&#xD;
&#xD;
               -  not be breastfeeding or plan to breastfeed through completion of the study,&#xD;
&#xD;
               -  agree to use a medically acceptable method of preventing conception from the&#xD;
                  screening visit through completion of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Presence of superficial reflux,&#xD;
&#xD;
          2. Presence of untreated iliac/IVC obstruction greater than 50% in diameter reduction,&#xD;
&#xD;
          3. Previously documented hypercoagulable condition that cannot be adequately treated with&#xD;
             anticoagulation,&#xD;
&#xD;
          4. Previous open surgical procedure in the ipsilateral deep venous system,&#xD;
&#xD;
          5. Venous stent in the ipsilateral femoral or popliteal vein,&#xD;
&#xD;
          6. Extensive infrainguinal obstruction of the venous system,&#xD;
&#xD;
          7. DVT or pulmonary embolism within 30 days of the planned procedure,&#xD;
&#xD;
          8. Active malignancy excepting non-melanoma skin cancer,&#xD;
&#xD;
          9. Arterial insufficiency with measured ABI &lt;0.70&#xD;
&#xD;
         10. Lymphedema not due to venous disease,&#xD;
&#xD;
         11. Current or planned participation in another clinical trial within 30 days of&#xD;
             treatment,&#xD;
&#xD;
         12. Minor venous procedures (e.g., superficial vein procedures or venous stenting) within&#xD;
             6 weeks of screening,&#xD;
&#xD;
         13. New York Heart Association Class III or greater,&#xD;
&#xD;
         14. Fibromyalgia,&#xD;
&#xD;
         15. Chronic narcotic usage,&#xD;
&#xD;
         16. Positive COVID-19 test within the last 3 months.&#xD;
&#xD;
         17. Other medical conditions or comorbidities which, in the opinion of the investigator,&#xD;
             would interfere with study compliance,&#xD;
&#xD;
         18. Contraindication to anticoagulation,&#xD;
&#xD;
         19. Stainless steel sensitivity/ porcine tissue sensitivity,&#xD;
&#xD;
         20. Active superficial thrombophlebitis,&#xD;
&#xD;
         21. Thrombocytosis with platelet count &gt; 1 million/microliter,&#xD;
&#xD;
         22. Unwilling or unable to comply with post-operative anticoagulation regimen.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Glickman, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hancock Jaffe Laboratories, Inc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Natalie Guzman</last_name>
    <phone>832-473-4684</phone>
    <email>NGuzman@hancockjaffe.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marc Glickman, MD</last_name>
    <phone>757-573-7518</phone>
    <email>MGlickman@hancockjaffe.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rebecca St. John</last_name>
      <phone>205-934-7279</phone>
      <email>rstjohn@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Marc Passman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pima Heart and Vascular</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85719</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Monica Varela</last_name>
      <phone>520-975-6400</phone>
      <email>monica.varela@Pimaheartandvascular.com</email>
    </contact>
    <investigator>
      <last_name>Scott Berman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedar Sinai</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Thottam</last_name>
      <phone>310-423-3081</phone>
      <email>Maria.Thottam@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Allan Tulloch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale school of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcus Harrison</last_name>
      <phone>203-737-7721</phone>
      <email>marcus.harrison@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Iyad Ochoa Chaar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Miami Vascular Specialists</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aileen Rodriguez</last_name>
      <email>AileenRo@baptisthealth.net</email>
    </contact>
    <investigator>
      <last_name>Michele Taubman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Farah Ahmed</last_name>
      <phone>773-834-3336</phone>
      <email>faraha@bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Chelsea Dorsey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Louis University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Craig Dedert</last_name>
      <phone>314-977-4723</phone>
      <email>craig.dedert@health.slu.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew Smeds, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Englewood Health</name>
      <address>
        <city>Englewood</city>
        <state>New Jersey</state>
        <zip>07631</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nathalia Clark</last_name>
      <phone>201-894-3088</phone>
      <email>nathlaia.clark@ehmchealh.org</email>
    </contact>
    <investigator>
      <last_name>Steven Elias, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenda Romeo</last_name>
      <phone>518-262-8579</phone>
      <email>romeob@amc.edu</email>
    </contact>
    <investigator>
      <last_name>Adriana Laser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Langone</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacqueline Bott</last_name>
      <phone>212-263-2268</phone>
      <email>jacqueline.bott@nyulangone.org</email>
    </contact>
    <investigator>
      <last_name>Mike Sadek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stony Brook Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrew Bryan</last_name>
      <phone>631-406-9446</phone>
      <email>andrew.bryan@stonybrookmedicine.edu</email>
    </contact>
    <investigator>
      <last_name>Antonios Gasparis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27516</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zachary Gortler</last_name>
      <phone>919-843-1268</phone>
      <email>zachary_gortler@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>William Marston, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>TriHealth</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lavonda Kirkland</last_name>
      <phone>513-862-2877</phone>
      <email>lavonda_kirkland@trihealth.com</email>
    </contact>
    <investigator>
      <last_name>Patrick Muck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jobst Vascular Institute / Promedica Toledo Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Hallett</last_name>
      <phone>419-291-8792</phone>
      <email>kelly.hallett@promedica.org</email>
    </contact>
    <investigator>
      <last_name>Greg Kasper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julianna Sheline</last_name>
      <phone>412-443-4843</phone>
      <email>shelinej@upc.edu</email>
    </contact>
    <investigator>
      <last_name>Rabih Chaer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruth Medcalf</last_name>
      <phone>346-238-1131</phone>
      <email>rmedcalf@houstonmethodist.org</email>
    </contact>
    <investigator>
      <last_name>Eric Peden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sarah Havert</last_name>
      <phone>757-388-2991</phone>
      <email>SSHAVERT@sentara.com</email>
    </contact>
    <investigator>
      <last_name>David Dexter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lake Washington Vascular</name>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <zip>98004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kim Glorieux</last_name>
      <phone>425-732-5958</phone>
      <email>KimG@lkwv.com</email>
    </contact>
    <investigator>
      <last_name>Kathleen Gibson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 21, 2021</study_first_submitted>
  <study_first_submitted_qc>June 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Venous Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

